The UDI exception has its own deadline

A device with no UDI on its label is not automatically a device out of compliance. FDA’s own regulation says so, in the same rule that requires the UDI in the first place — and it says so with a deadline attached that is easy to read past.

One rule, staggered by class

The 2013 Unique Device Identification final rule didn’t set one compliance date; it set several, staggered by device class under 21 CFR 801.20. Class III devices and implantable, life-supporting, or life-sustaining devices came first, in 2014 and 2015. Class II devices followed in 2016. Class I and unclassified devices — the largest population, by count — came last, and FDA extended their compliance date more than once by guidance before it finally landed. Direct marking of reusable devices, under 21 CFR 801.45, runs on its own, later schedule again. A device’s class alone determines which of several dates governs it, and none of those dates is retroactive to devices that already existed.

The exception, and its own clock

21 CFR 801.30(a)(1) is the provision that makes the staggered dates workable at all: a finished device manufactured and labeled before the compliance date that applies to it is excepted from bearing a UDI, full stop — nothing in the rule requires a manufacturer to recall or relabel existing inventory just because the calendar turned. But the exception is not open-ended. The same paragraph puts a limit on itself: the exception expires three years after the compliance date it attaches to, for that device. A unit made and labeled the day before a Class II device’s 2016 compliance date could sit in a distributor’s inventory, lawfully unlabeled, only until 2019 — not indefinitely, and not until it happens to sell. The regulation also carves the exception narrower than a reader might assume: it never applies to implantable devices, and it never covers the outer package a grandfathered device ships in, only the device itself.

A missing UDI can mean the device predates its compliance date. It can also mean the three-year window on that fact has already closed.

The practice

Finding a device without a UDI — on a competitor’s product, in a distributor’s catalog, on a unit pulled for a quality investigation — is not by itself evidence of noncompliance, and it is also not evidence of the opposite. What it actually shows depends on three facts together: the device’s class, the compliance date 21 CFR 801.20 set for that class, and how long ago that date passed. Inside three years of the applicable date, an absent UDI is consistent with old, lawfully grandfathered stock. Past that window, it isn’t. None of that reasoning reaches implantable devices, which never had the exception to begin with. This is a description of how one labeling exception is scoped and timed under FDA’s own regulation, never a determination that any specific device, found without a UDI, is or isn’t in compliance — that reading is a regulatory professional’s, done against the specific device’s own manufacture and label date. Per what FDA Radar monitors and how often, UDI status is not one of the fields the pipeline’s four sources carry today.